Mayo Clinic Workshop in Plasma Cell Disorders: Robert Kyle Symposium 2021
Mayo Clinic Workshop in Plasma Cell Disorders: Robert Kyle Symposium 2021 is organized by Mayo Clinic and will be held from May 22 - 23, 2021.
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
May 22, 2021 (Livestream- CT) will provide education to Medical Professionals for CME Credit.
May 23, 2021 (Livestream - CT) will provide education to patients, families and caregivers in the areas of Multiple Myeloma, Al Amyloidosis, and Waldenstrom Macroglobulinemia.
There are numerous new and established drug therapies and protocols for plasma cell disorders, including AL amyloidosis, Waldenstrom’s macroglobulinemia and multiple myeloma. This CME course introduces health care professionals at all levels to the latest practices in the treatment of plasma cell disorders. The conference provides “bench-to-bedside” overview of novel drug therapies for the general oncologist, resident, fellow, or advanced practice provider who is unfamiliar with current clinical trials and treatments.
• Panel discussions with top researchers and clinicians who are leading clinical trials that will benefit patients seen by attendees
• Content directly focused on the types of clinical cases general hematologists/oncologists are seeing in their clinics and hospitals
• Q&A with faculty about real clinical scenarios
• Special recognition of Dr. Robert Kyle, Mayo Clinic emeritus, who will be present and speak at the event.
Concurrent with the scientific program for physicians and healthcare professionals, there will be a separate patient-oriented symposium. Registration for the patient symposium is free for patients and their family members.
Upon conclusion of this program, participants should be able to:
• Interpret new, practice-relevant data in diagnosing and risk stratifying monoclonal plasma cell disorders.
• Integrate evidence-based treatment strategies into clinical practice for Monoclonal gammopathies.
• Integrate supportive care approaches into treatment of plasma cell disorders.
- CME : 6.25
Toll free Number
Browse CME / CE Conferences by Specialty View All
- Clinical Pharmacology
- Emergency Medicine
- Endocrinology, Metabolism and Diabetes
- Healthcare Management
- Infectious Disease
- Medical Education
- Obstetrics and Gynecology
- Pain Management
- Pharmacy and Medicine
- Primary Care
- Pulmonary Medicine